REMI — Remedent Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- $0.01m
- $0.01m
- $1.06m
Annual cashflow statement for Remedent, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2016 March 31st | 2017 March 31st | 2018 March 31st | 2019 March 31st | 2020 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 0.177 | 0.827 | -0.043 | 2.12 | -0.854 |
| Depreciation | |||||
| Non-Cash Items | -0.282 | -1.28 | -0.171 | -2.94 | 0.326 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.256 | 1.97 | 0.134 | 1.29 | 0.559 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.203 | 1.67 | 0.02 | 0.567 | 0.102 |
| Capital Expenditures | -0.116 | -0.038 | -0.004 | 0 | — |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.116 | -0.038 | -0.004 | 0 | — |
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0 | -1 | 0 | — | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.305 | 0.053 | -0.054 | -0.026 | 0.048 |